Long-term treatment with nipocalimab led to sustained reductions in symptom severity among antibody-positive patients with generalized myasthenia gravis…
Marisa Wexler, MS
senior science writer
Marisa Horak joined Bionews in 2018 right after she completed her master’s degree in cellular and molecular pathology. She has dedicated her career to making scientific and medical information more accessible to people affected by rare and chronic disorders.
Education
- MS, Cellular and Molecular Pathology, University of Pittsburgh
- BS, Microbiology, Michigan State University
Professional Accomplishments
- Universal concept signature analysis: genome-wide quantification of new biological and pathological functions of genes and pathways, 2019, Briefings in Bioinformatics
- Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity, 2018, Oncotarget
- Insights on processes of evolutionary tumor growth, 2016, Atlas Genet Cytogenet Oncol Haematol
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Treatment with the cell therapy Descartes-08 led to long-term reductions in symptom severity for people with myasthenia gravis…
Scientists in Korea have developed a cell-based test that can be used to detect antibodies against agrin, a protein involved…
More than 500 members of the myasthenia gravis (MG) community are expected at a conference featuring strategies for patient education,…
One year of treatment with inebilizumab eased symptoms and improved daily functioning for people with generalized myasthenia gravis…
Repeated cycles of Rystiggo (rozanolixizumab-noli) do not increase the risk of safety problems in people with generalized myasthenia…
Rituximab can safely and effectively control myasthenia gravis (MG) in patients with antibodies against muscle-specific kinase or MuSK,…
Tofacitinib, an approved medication for some types of inflammatory arthritis and inflammatory bowel disease, may also help treat myasthenia…
Top-line results from a Phase 3 clinical trial of batoclimab in people with generalized myasthenia gravis (gMG) are expected…
Nipocalimab outperformed a placebo at easing the severity of generalized myasthenia gravis (gMG) in a Phase 3 clinical…